Patents by Inventor Benjamin Julius
Benjamin Julius has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250146902Abstract: Systems, methods, and devices for inspection, under a microscope, of end connectors of fiber optic cables are provided. In one aspect, a light ring including a circular array of light sources provides darkfield illumination to an end connector being inspected under a microscope. Each of the light sources may be lit in series and the resulting shadows may be used to identify dirt on the end connector, as well as to determine whether any dirt identified on the end connector can be cleaned off. In another aspect, a light ring combined with a redirection ring (e.g., a reflector and/or refractor ring) may provide darkfield illumination. In yet another aspect, a series of images may be captured and analyzed to automatically identify dirt on the end connector, as well as to determine whether any identified dirt can be cleaned off.Type: ApplicationFiled: November 8, 2023Publication date: May 8, 2025Applicant: VIAVI SOLUTIONS INC.Inventors: Joshua Benjamin Julius PHILIPSON, Kevin CASSADY, Nicklos Joseph BULITKA, Christopher Russell WAGNER, Christian Richard COMTOIS-ARNALDO
-
Publication number: 20250145974Abstract: Provided herein are compositions, systems, and methods comprising engineered effector proteins and uses thereof. These effector proteins may be characterized as CRISPR-associated (Cas) proteins. Various compositions, systems, and methods of the present disclosure may leverage the activities of these effector proteins for the modification, detection, and engineering of nucleic acids.Type: ApplicationFiled: November 6, 2024Publication date: May 8, 2025Inventors: Wiputra Jaya HARTONO, Pei-Qi LIU, Lucas Benjamin HARRINGTON, Aaron DELOUGHERY, William Douglass WRIGHT, Stepan TYMOSHENKO, Benjamin Julius RAUCH
-
Publication number: 20250066797Abstract: Provided herein, in certain embodiments, are programmable nucleases, guide nucleic acids, and complexes thereof. Certain programmable nucleases provided herein comprise a RuvC domain. Also provided herein are nucleic acids encoding said programmable nucleases and guide nucleic acids. Also provided herein are methods of genome editing, methods of regulating gene expression, and methods of detecting nucleic acids with said programmable nucleases and guide nucleic acids.Type: ApplicationFiled: May 23, 2024Publication date: February 27, 2025Inventors: Lucas Benjamin HARRINGTON, William Douglass WRIGHT, Pei-Qi LIU, Benjamin Julius RAUCH, Wiputra Jaya HARTONO, Bridget Ann Paine MCKAY, Danuta Sastre PHIPPS, Yuxuan ZHENG, Nerea SANVISENS, Sean CHEN, David PAEZ-ESPINO
-
Patent number: 12222551Abstract: A variable optical attenuator (VOA) may include an input collimator with an input fiber connected on one side and an output collimator with an output fiber connected on one side, where the collimators are on a same surface of a VOA enclosure. A retroreflector may receive a light beam from the input collimator and reflect the light beam to the output collimator. The VOA may include an attenuation element positioned between the input collimator and the retroreflector and/or another attenuation element positioned between the retroreflector and the output collimator to provide variable attenuation to the light beam. The attenuation elements may be moved to set an attenuation level by one or more adjustment elements such as a miniature motor. The attenuation element may include a gradient index (GRIN) element, a polarizer, a neutral density filter, or a wavelength tunable filter.Type: GrantFiled: September 6, 2022Date of Patent: February 11, 2025Assignee: VIAVI SOLUTIONS INC.Inventors: Driss Touahri, Joshua Benjamin Julius Philipson, Christopher Russell Wagner, Luis Andre Neves Paiva Fernandes, Robert Matthew Adams
-
Patent number: 12174066Abstract: A system for a high resolution optical spectrum analyzer (OSA) using various optical configurations to reduce polarization dependent loss (PDL) is disclosed. The system may include a birefringent element to receive an input optical beam. The birefringent element may then split the optical beam into at least two exit beams. The system may also include an optical configuration comprising at least one optical element. The optical configuration may receive the at least two exit beams from the birefringent element and transform at least one of the two exit beams using the at least one optical element to provide two parallel beams with parallel polarizations. The optical configuration may then output the two parallel beams with parallel polarizations to a downstream optical element, such as a diffraction grating, or other optical element.Type: GrantFiled: October 13, 2023Date of Patent: December 24, 2024Assignee: VIAVI SOLUTIONS INC.Inventors: Driss Touahri, Christopher Russell Wagner, Joshua Benjamin Julius Philipson
-
Publication number: 20240366678Abstract: Provided herein are compositions, systems, and methods for engineering hematopoietic stem cells that engineered by using polypeptides, such as effector proteins, and guide nucleic acids. Also, provided herein are the engineered hematopoietic stem cells, methods of manufacturing such hematopoietic stem cells, and methods of treating a disease or disorder using such hematopoietic stem cells.Type: ApplicationFiled: May 2, 2024Publication date: November 7, 2024Inventors: Mark Alan DEWITT, Siming XU, William Douglass WRIGHT, Stepan TYMOSHENKO, Benjamin Julius RAUCH, Wiputra Jaya HARTONO, Aaron DELOUGHERY, Lucas Benjamin HARRINGTON
-
Publication number: 20240327810Abstract: The present disclosure provides compositions of effector proteins. The compositions may comprise engineered guide nucleic acids. Also disclosed are the methods and systems for detecting and modifying target nucleic acids using the same. The compositions may provide nucleic acid modification and/or detection at relatively high temperatures.Type: ApplicationFiled: November 3, 2023Publication date: October 3, 2024Inventors: James Paul BROUGHTON, Janice Sha Chen, Jesus Ching, Clare Louise Fasching, Lucas Benjamin Harrington, Lior Kreindler, Bridget Ann Paine Mckay, David Paez-Espino, Benjamin Julius Rauch, Matthew Verosloff, William Douglass Wright
-
Publication number: 20240301379Abstract: Provided herein are compositions, systems, and methods comprising effector proteins and uses thereof. These effector proteins may be characterized as CRISPR-associated (Cas) proteins. Various compositions, systems, and methods of the present disclosure may leverage the activities of these effector proteins for the modification, detection, and engineering of nucleic acids.Type: ApplicationFiled: May 29, 2024Publication date: September 12, 2024Applicant: Mammoth Biosciences, Inc.Inventors: Lucas Benjamin HARRINGTON, David PAEZ-ESPINO, Benjamin Julius RAUCH, Stepan TYMOSHENKO
-
Patent number: 12077775Abstract: Provided herein are compositions, systems, and methods comprising effector proteins and uses thereof. These effector proteins are shown to be active with guide RNAs and may be characterized as CRISPR-associated (Cas) proteins. Various compositions, systems, and methods of the present disclosure leverage the activities of these effector proteins for the modification, detection, and engineering of nucleic acids.Type: GrantFiled: June 12, 2023Date of Patent: September 3, 2024Assignee: Mammoth Biosciences, Inc.Inventors: Aaron Deloughery, Matan Drory Retwitzer, Lucas Benjamin Harrington, Wiputra Jaya Hartono, Alexander Richard Neckelmann, David Paez-Espino, Benjamin Julius Rauch, Clarissa Oriel Rhines, Stepan Tymoshenko, Fnu Yunanda, William Douglass Wright
-
Publication number: 20240271113Abstract: Provided herein are compositions, systems, and methods comprising effector proteins and uses thereof. These effector proteins may be characterized as CRISPR-associated (Cas) proteins. Various compositions, systems, and methods of the present disclosure may leverage the activities of these effector proteins for the modification, detection, and engineering of nucleic acids.Type: ApplicationFiled: February 23, 2024Publication date: August 15, 2024Applicant: Mammoth Biosciences, Inc.Inventors: Lucas Benjamin HARRINGTON, David PAEZ-ESPINO, Benjamin Julius RAUCH, Stepan TYMOSHENKO
-
Patent number: 12038346Abstract: According to examples, a system for measuring polarization dependent loss (PDL) for a device-under-test (DUT) may include a tunable laser, a polarization element and a power meter. The tunable laser may emit an optical signal to sweep across an optical band at a constant rate. The polarization element may scramble polarizations states of the optical signal emitted from the tunable laser. The power meter may take power measurements associated with the optical signal emitted from the tunable laser, wherein the power measurements from the power meter are used to determine a maximum insertion loss (IL) and a minimum insertion loss (IL) associated with the device-under-test (DUT). An average insertion loss (IL) and a polarization dependent loss (PDL) for the device-under-test (DUT) may be calculated based on the maximum insertion loss (IL) and the minimum insertion loss (IL) associated with the device-under-test (DUT).Type: GrantFiled: June 7, 2021Date of Patent: July 16, 2024Assignee: VIAVI SOLUTIONS INC.Inventors: Luis Andre Neves Paiva Fernandes, Robert Matthew Adams, Christopher Russell Wagner, Joshua Benjamin Julius Philipson, Eugene Chan
-
Publication number: 20240226327Abstract: Provided herein are compositions, systems, and methods comprising effector proteins, effector partners, and uses thereof. These effector proteins may be characterized as CRISPR-associated (Cas) proteins. Various compositions, systems, and methods of the present disclosure may leverage the activities of these effector proteins for the modification, detection, and/or engineering of nucleic acids.Type: ApplicationFiled: September 18, 2023Publication date: July 11, 2024Inventors: Timothy Robert ABBOTT, Aaron DELOUGHERY, David PAEZ-ESPINO, Benjamin Julius RAUCH
-
Publication number: 20240191281Abstract: The present disclosure provides compositions and methods of use for a Type VI CRISPR/Cas nuclease. Type VI CRISPR/Cas nucleases are able to bind to a target nucleic acid, thereby activating trans-collateral nuclease activity on nucleic acid reports. Furthermore, the present disclosure provides methods to modify ribonucleic acid sequences using the programmable nucleases disclosed herein.Type: ApplicationFiled: August 2, 2023Publication date: June 13, 2024Inventors: Benjamin Julius RAUCH, Aaron DELOUGHERY, Matan DRORY RETWITZER, David PAEZ-ESPINO, Caleb TRECAZZI, Lucas Benjamin HARRINGTON, Janice Sha CHEN, James Paul BROUGHTON, Clarissa Oriel RHINES, William Douglass WRIGHT, Matthew VEROSLOFF, Carley Gelenter HENDRIKS
-
Publication number: 20240191280Abstract: The present disclosure describes CRISPR/Cas proteins and guide RNA combinations that are capable of modifying nucleic acids at high temperatures. These compositions are especially useful for systems and methods of nucleic acid detection, including diagnostic devices.Type: ApplicationFiled: November 10, 2023Publication date: June 13, 2024Inventors: William Douglass WRIGHT, Benjamin Julius RAUCH, Aaron DELOUGHERY, James Paul BROUGHTON
-
Publication number: 20240173433Abstract: The present disclosure provides compositions and methods of use for Type V CRISPR/Cas proteins. Type V CRISPR/Cas proteins may be configured to bind and modify nucleic acids in a sequence specific manner.Type: ApplicationFiled: October 4, 2023Publication date: May 30, 2024Inventors: Benjamin Julius RAUCH, Aaron Deloughery, William Douglass Wright, David Paez-Espino
-
Publication number: 20240175059Abstract: Provided herein are compositions, systems, and methods comprising effector proteins and uses thereof. These effector proteins are shown to be active with guide RNAs and may be characterized as CRISPR-associated (Cas) proteins. Various compositions, systems, and methods of the present disclosure leverage the activities of these effector proteins for the modification, detection, and engineering of nucleic acids.Type: ApplicationFiled: December 4, 2023Publication date: May 30, 2024Inventors: Aaron DELOUGHERY, Matan Drory Retwitzer, Lucas Benjamin Harrington, Wiputra Jaya Hartono, Alexander Richard Neckelmann, David Paez-Espino, Benjamin Julius Rauch, Clarissa Oriel Rhines, Stepan Tymoshenko, Fnu Yunanda, William Douglass Wright
-
Publication number: 20240131187Abstract: Provided herein are compositions, systems, and methods comprising effector proteins, effector partners, and uses thereof. These effector proteins may be characterized as CRISPR-associated (Cas) proteins. Various compositions, systems, and methods of the present disclosure may leverage the activities of these effector proteins for the modification, detection, and/or engineering of nucleic acids.Type: ApplicationFiled: September 17, 2023Publication date: April 25, 2024Inventors: Timothy Robert ABBOTT, Aaron DELOUGHERY, David PAEZ-ESPINO, Benjamin Julius RAUCH
-
Publication number: 20240110831Abstract: A system for a high resolution optical spectrum analyzer (OSA) using various optical configurations to reduce polarization dependent loss (PDL) is disclosed. The system may include a birefringent element to receive an input optical beam. The birefringent element may then split the optical beam into at least two exit beams. The system may also include an optical configuration comprising at least one optical element. The optical configuration may receive the at least two exit beams from the birefringent element and transform at least one of the two exit beams using the at least one optical element to provide two parallel beams with parallel polarizations. The optical configuration may then output the two parallel beams with parallel polarizations to a downstream optical element, such as a diffraction grating, or other optical element.Type: ApplicationFiled: October 13, 2023Publication date: April 4, 2024Applicant: VIAVI SOLUTIONS INC.Inventors: Driss TOUAHRI, Christopher Russell WAGNER, Joshua Benjamin Julius PHILIPSON
-
Publication number: 20240077678Abstract: A variable optical attenuator (VOA) may include an input collimator with an input fiber connected on one side and an output collimator with an output fiber connected on one side, where the collimators are on a same surface of a VOA enclosure. A retroreflector may receive a light beam from the input collimator and reflect the light beam to the output collimator. The VOA may include an attenuation element positioned between the input collimator and the retroreflector and/or another attenuation element positioned between the retroreflector and the output collimator to provide variable attenuation to the light beam. The attenuation elements may be moved to set an attenuation level by one or more adjustment elements such as a miniature motor. The attenuation element may include a gradient index (GRIN) element, a polarizer, a neutral density filter, or a wavelength tunable filter.Type: ApplicationFiled: September 6, 2022Publication date: March 7, 2024Applicant: VIAVI SOLUTIONS INC.Inventors: Driss TOUAHRI, Joshua Benjamin Julius Philipson, Christopher Russell Wagner, Luis Andre Neves Paiva Fernandes, Robert Matthew Adams
-
Patent number: 11828648Abstract: A system for a high resolution optical spectrum analyzer (OSA) using various optical configurations to reduce polarization dependent loss (PDL) is disclosed. The system may include a birefringent element to receive an input optical beam. The birefringent element may then split the optical beam into at least two exit beams. The system may also include an optical configuration comprising at least one optical element. The optical configuration may receive the at least two exit beams from the birefringent element and transform at least one of the two exit beams using the at least one optical element to provide two parallel beams with parallel polarizations. The optical configuration may then output the two parallel beams with parallel polarizations to a downstream optical element, such as a diffraction grating, or other optical element.Type: GrantFiled: May 28, 2021Date of Patent: November 28, 2023Assignee: VIAVI SOLUTIONS INC.Inventors: Driss Touahri, Christopher Russell Wagner, Joshua Benjamin Julius Philipson